PHI with Peritoneal tuberculosis
How does this condition affect your private health insurance?
Peritoneal tuberculosis is an extrapulmonary form of tuberculosis caused by Mycobacterium tuberculosis, affecting the peritoneum, the lining of the abdominal cavity. It commonly results from hematogenous or lymphatic spread from a primary pulmonary or gastrointestinal source, or direct spread from adjacent organs. Symptoms are often non-specific, including abdominal pain, distension, fever, weight loss, and ascites. Diagnosis can be challenging, requiring imaging, ascitic fluid analysis, and peritoneal biopsy for histological and microbiological confirmation. If left untreated, it can lead to complications like bowel obstruction or fistulae. Treatment involves a standard multi-drug anti-tuberculosis regimen, typically for 6-9 months, with excellent prognosis if diagnosed early and treated appropriately.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months (if untreated or until effective treatment commences)
Duration of Illness (Lifetime)
One-time event (with appropriate and complete treatment); chronic or recurrent if treatment is incomplete or fails
Cost of Treatment (Initial)
High (diagnostic tests, potentially hospitalization, and 6-9 months of multi-drug therapy)
Cost of Treatment (Lifetime)
Primarily the cost of the initial treatment; significantly higher if relapse or severe complications occur
Mortality Rate
Low to moderate with timely and effective treatment; high if untreated or with severe complications, especially in immunocompromised individuals
Risk of Secondary Damages
Moderate to high (e.g., bowel obstruction, adhesions, fistulae, chronic pain, infertility in women)
Probability of Full Recovery
High (over 90%) with prompt diagnosis and adherence to the full anti-tuberculosis treatment regimen
Underlying Disease Risk
Moderate to high (e.g., HIV infection, diabetes mellitus, malnutrition, other forms of tuberculosis, or immunosuppression)